Trial intelligence / Profile preview

Aliskiren vs Amlodipine in Diabetic Hypertensive Patients

NCT01409408Phase 4Withdrawn

Sponsor
Hospital Universitário Pedro Ernesto
Start
Apr 2011
Primary completion
Apr 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of aliskiren in hypertension (HTN), sponsored by Hospital Universitário Pedro Ernesto. Planned start Apr 2011; status: withdrawn.

02

Drugs

aliskiren
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT01409408.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01409408.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call